Market research
300298.SHE Sinocare Inc
SHE CNY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 9B
- P/E ratio
- 65.16
- Analyst target
- 22.88
- Dividend yield
- Not available
- Beta
- -0.12
Profile
Company facts
- Exchange
- SHE
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CNE100001CJ0
- Market cap
- 9B
- P/E ratio
- 65.16
- Analyst target
- 22.88
- Dividend yield
- Not available
- Beta
- -0.12
About
About Sinocare Inc
Sinocare Inc. provides digital diabetes management products in the People's Republic of China. It offers blood and pressure products, multiparameter testing, and hospital and primary healthcare products; H102 Air, a hemoglobin monitoring system; and Safe AQ UA II, a uric acid monitoring system. The company also exports its products. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 300298.SHE discussion.
5 years, 5 months ago
Sinocare Inc is currently in a long term downtrend where the price is trading 11.1% below its 200 day moving average.
From a valuation standpoint, the stock is 12.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.4.
Sinocare Inc's total revenue rose by 25.5% to $557M since the same quarter in the previous year.
Its net income has increased by 8.8% to $91M since the same quarter in the previous year.
Finally, its free cash flow grew by 1240.3% to $73M since the same quarter in the previous year.
Based on the above factors, Sinocare Inc gets an overall score of 4/5.